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Abstract 
Scope 
Previous work highlighted the potential of odd-chain length saturated fatty acids as potential 
markers of dairy intake. The aim of this study was to assess the reproducibility of these 
biomarkers and their sensitivity to changes in dairy intake.  
Methods and Results 
Fatty acid profiles and dietary intakes from food frequency questionnaires (FFQs) were 
measured three times over six months in the Food4Me Study. Reproducibility was explored 
through intra-class correlation coefficients (ICCs) and within-subject coefficients of variation 
(WCV). Sensitivity to changes in diet was examined using regression analysis. C15:0 blood 
levels showed high correlation over time (ICC: 0.62, 95% CI: 0.57, 0.68), however, the ICC 
for C17:0 was much lower (ICC: 0.32, 95% CI: 0.28, 0.46). The WCV for C15:0 was 16.6% 
and that for C17:0 was 14.6%. There were significant associations between changes in intakes 
of total dairy, high-fat dairy, cheese and butter and C15:0; and change in intakes of high-fat 
dairy and cream and C17:0.  
Conclusions 
Results provide evidence of reproducibility of C15:0 levels over time and sensitivity to change 
in intake of high-fat dairy products with results comparable to the well-established biomarker 
of fish intake (EPA+DHA). 
  
 1 Introduction  
Pentadecanoic acid (C15:0) and heptadecanoic acid (C17:0) are linear odd-chained 
fatty acids found mainly in the milk and meat fat of ruminants such as cattle and sheep [1]. 
These saturated fatty acids originate both from bacterial synthesis in the reticulo-rumen of these 
animals, as well as from synthesis in their mammary glands [2]. In humans, these fatty acids 
have been proposed as potential biomarkers of intake of high-fat dairy foods [3-6], and as such 
are of interest to researchers studying the effects of dairy fats on health conditions like 
cardiovascular disease and type-2 diabetes. In a study of 1595 Coronary Heart Disease (CHD) 
cases and 2246 controls, the concentrations of C15:0 and C17:0 in the phospholipid fraction of 
human blood were inversely related to CHD incidence [7]. Similarly, a systematic review and 
meta-analysis of four fatty acid biomarkers and coronary risk showed a negative association of 
coronary risk with C17:0, and with C17:0 + C15:0 [8]. Furthermore, a recent study 
demonstrated that plasma phospholipid C15:0 and C17:0 concentrations had strong inverse 
associations with type 2 diabetes risk [9].  
As with other dietary biomarkers, the potential to investigate C17:0 and C15:0 blood 
levels in large prospective cohort studies is likely to increase with the expansion in use of more 
cost-effective methods for collecting biological samples, such as dried blood spots (DBS) [10, 
11]. However, the usefulness of C17:0 and C15:0 as measures of exposure is contingent on the 
within-individual reproducibility over time in concentration of these biomarkers, i.e. on 
evidence that a single baseline measure –as is common in cohort studies– provides an accurate 
account of individuals’ typical or habitual dietary exposure [12]. The relevance of C17:0 and 
C15:0 as biomarkers of high-fat dairy intake also requires evidence of the sensitivity of these 
fatty acids to changes in diets. Therefore, the objective of this study was to explore the 
reproducibility over time of repeated measurements done on the same study participants, and 
the sensitivity to reported change in dairy intake, of blood C17:0 and C15:0 levels. The 
hypothesis was that C17:0 and C15:0 fatty acids would demonstrate good reproducibility over 
time in individuals with stable dairy intakes, and sensitivity to change with change in dairy 
intake habits in a similar population of adults. 
2 Materials and methods 
2.1 Overview 
Data originate from the web-based Food4Me personalized nutrition proof-of-principle 
study (Clinicaltrials.gov RCT number NCT01530139) [13]. Briefly, the study compared the 
effects of different levels of personalised nutrition advice on health-related outcomes with the 
same outcomes in a group receiving only generic nutrition advice, as described in detail in 
Celis-Morales et al. [14]. Recruitment was done across seven European countries (Germany, 
Greece, Ireland, the Netherlands, Poland, Spain and the United Kingdom). Participants in each 
country were randomized into the Generic-advice1 group or any of three personalised-advice2 
Intervention groups. Baseline measurements (t0) of dietary intakes and biomarkers were 
followed up at three (t3) and six months (t6) for all participants. Variability over time of C15:0 
and C17:0 levels was studied using the Generic-advice arm of the Food4Me study (individuals 
with greater stability in dietary intakes over time), while sensitivity to change in dairy intake 
of C15:0 and C17:0 levels was studied using pooled data from participants randomised to the 
Intervention groups (individuals with changing diets over time).  Results for C17:0 and C15:0 
levels in whole blood were compared with values obtained for the sum of eicosapentaenoic 
                                                 
1 Dietary advice for this group was based on (European) population guidelines. Information was also 
given on body weight and physical activity based on (European) population guidelines. 
2 One group was given dietary advice based on individual dietary intake data alone, another group was 
given advice based on individual dietary intake an phenotypic data, and a third group was given information on 
individual dietary intake, phenotypic data and genotypic data. 
acid (EPA) and docosahexaenoic acid (DHA), a well-established biomarker of oily fish intake 
[15], as a measure to benchmark the reproducibility and sensitivity values of C15:0 and C17:0.  
2.2 Study sample 
DBS samples, dietary intakes and anthropometric data were collected from an adult 
sample (≥18 years) over six months from August 2012 to February 2014 as part of the Food4Me 
study.  
2.3 Assessment of blood fatty acids 
Two DBS cards (Vitas Ltd, Oslo) were used to collect approximately 5 drops of blood 
(150µl) per card on each occasion [14]. The blood spots were left to dry at room temperature 
for at least 2 hours but not more than 4 hours, and then sent for processing and analysis (Vitas 
Ltd, Norway). Once removed from the DBS sample, the dried human whole blood was directly 
methylated with sodium methylate. After incubation at 50⁰C, the formed fatty acid methyl 
esters (FAMES) were extracted into hexane and analysed on an Agilent Technologies gas-
liquid chromatograph with a flame-ionization detector (GC-FID). The fatty acid methyl esters 
were separated on a Supelco 30µm x 250µm x 0.2µm column and reported as g/100 gram 
FAME (weight percentage). 
2.4 Assessment of dietary intake 
Habitual food intake over the previous month was assessed using an on-line food 
frequency questionnaire (FFQ) with 157 food items frequently consumed in all the countries 
represented in the study and developed specifically for the Food4Me intervention. Participants 
replied how often in the past month they had eaten each of the food items using nine response 
categories ranging from “never (<1 per month)” to “6+ per day”, after which they indicated 
their usual serving size among seven possibilities from a range of portion size colour 
photographs. The list of dairy food products covered in the FFQ included cream (double and 
single), high-fat cheese (e.g. stilton, cheddar and brie), medium-fat cheese (e.g. goats’ cheese, 
camembert, feta and emmental), low-fat cheese (e.g. fresh mozzarella, cream cheese and 
katiki), very low-fat cheese (e.g. cottage cheese and quark), butter, milk (full-fat, low-fat and 
zero-fat), fruit mousse and yoghurt (fruit, full-fat, Greek and low-fat). The FFQ also covered 
other food categories that potentially contribute to C15:0 and C17:0 levels, such as ruminant 
meats (e.g. beef and beef products) and fish and fish products (e.g. oily fish, smoked salmon 
and sushi). 
Validation of the FFQ was done against the weighed food diaries and it was compared 
to the printed EPIC-Norfolk FFQ (CAMB/PQ/6/1205) [16-18]. Correlation of energy intake 
between the Food4Me FFQ and the EPIC-Norfolk FFQ was 0.68 (52% of cases in exact 
agreement), with the lowest correlation between the two instruments for polyunsaturated fatty 
acids (PUFA % total energy) at 0.43 (37% of cases in exact agreement). Correlations for dairy 
foods ranged from 0.55 (milk, 49% of exact agreement) to 0.7 (yoghurts, 58% of exact 
agreement) [17]. Correlations for red meat and meat products was greater than 0.67 (> 50% of 
exact agreement), and for fish and fish products > 0.70 (> 50% of exact agreement) [17]. 
Validity of the FFQ against a 4-day weighed food record (n=49) showed exact cross-
classification values from 41% (cheese) to 51% (milk) [18]. The final Food4Me FFQ showed 
good test-retest reproducibility (n=100, 2 occasions, 4 weeks apart) with Spearman correlation 
values between measurements ranging from 0.66 (cheese, 52% exact agreement) to 0.79 
(yoghurt, 58% of exact agreement) [18]. The categorization of dairy products into high-fat and 
low-fat was based on the fat content (g) per 100g of product with high fat defined as > 20g of 
fat /100g. 
Under-reporting of energy intake was identified using the lowest estimated energy 
requirement of 1.1 times the predicted basal metabolic rate [19]. Over-reporting of total energy 
intake was defined as values exceeding 18.84 MJ/day [13]. 
 2.5 Statistical analyses 
Differences in demographic characteristics and dietary intakes were explored using a 
repeated measures Skilling-Mack test (Friedman's ANOVA with missing values) for 
continuous non-normal variables, and logistic regression for binary variables. Comparison of 
blood fatty acid levels across time periods was done using a repeated measures ANOVA using 
Box’s conservative correction factor p-values. 
Reproducibility analyses 
Reproducibility over time of fatty acid levels was explored using three methods. Intra-
class correlation coefficients (ICCs) were calculated on the log-transformed fatty acid levels 
using the variance components from a random effects model (not controlling for time trend). 
The ICC in a one-way random-effects model measures the ratio of between-person variation 
over the total variation in the data. Higher ICC values indicate that more of the variance in the 
data comes from differences across individuals than from differences over time within 
individuals, therefore providing a degree of the reproducibility of replicate measures from the 
same subject [20: p.563]. In addition to ICCs, the within-subject coefficient of variation 
(WCVs) was calculated on the logarithm of the fatty acid levels using a one-way random effects 
model with MLE estimation [21]. The WCV provides a more generalizable estimation of 
reproducibility because, unlike the ICC, its value is not specific to a population or sample. 
Smaller values of the WCV indicate better reproducibility, i.e. lower within-person change 
across time. Finally, Spearman correlations of fatty acid measurements across the three time 
points of the study were also explored. Bootstraps with 1000 replications were used to calculate 
confidence intervals for all the measures of reproducibility. 
Sensitivity to dietary change analyses 
The change in fatty acid levels from changes in dairy intake (for C15:0 and C17:0) and 
fish intake (for EPA and DHA) were explored using first-difference linear regression [22] with 
clustered standard errors over individual participants (the model equations can be found in the 
online supplementary material). For the purpose of analyses, dairy intake was classed into daily 
portions of total dairy, high-fat dairy and low-fat dairy. High-fat dairy included double cream, 
high-fat cheese, medium-fat cheese and butter. Low-fat dairy included full-fat or whole milk, 
low-fat or semi-skimmed milk, zero-fat or skimmed milk, single or sour cream, fruit yoghurt 
or fruit mousse, full-fat Greek yoghurt, low-fat natural yoghurt, low-fat cheese, and very low-
fat cheese. In addition, individual products were grouped by product category into daily 
portions of milk, cream, yoghurt, cheese and butter. Intake of oily fish included consumption 
of cooked, raw and canned oily fish (the sample mean portions of the different product 
categories can be found in the online supplementary material). Models were run separately for 
all of these categories, with basic adjustment for total energy intake (MJ/day), age, smoking 
status and BMI. In addition, for the dairy intake models, results were adjusted for intake of 
ruminant meat and oily fish portions. Other covariates that did not change over the study period 
(e.g. sex and country of residence) were not included in the analyses [22].  
3 Results 
3.1 Sample characteristics 
After excluding observations with over- and under-reporting of energy intake (n=820) 
and extreme values of the fatty acid variables (n=11)3, the total number of observations over 
the three periods was 3148; 760 from the Control group and 2388 from the Intervention group. 
The total number of participants at was 334 in the Generic-advice group and 1054 in the 
                                                 
3 Cases which had unrealistically large or small values identified through box-plots of the data. 
Intervention arm of the Food4Me study. Table 1 presents the descriptive statistics for the 
Generic-advice and Intervention groups. Over the three periods, the average (±sd) age of 
participants was 40 years (±13) across both groups, with an average BMI of 27 kg/m2 (±4.2). 
Over time BMI and waist circumference decreased slightly for both groups, but the 
Intervention group had a larger reduction in total energy intake from fat, from an average of 
10.7% to 9.8% (Generic-advice group: 10.4% to 10.0%). Both groups were similar in the 
percentage energy intake from dairy (Generic-advice group: 13% ±6.6%), and the Generic-
advice group had a slightly higher contribution of fat from dairy (17.3% ±9%) compared to the 
Intervention group (16.1% ±8.2%). 
3.2 Dietary intakes 
Across the three periods, median (± interquartile range) intake of dairy products in the 
Generic-advice group was 314 (±277) g/day and 292. (±266) g/day in the Intervention group 
(Table 2). In both the Intervention and Generic-advice groups, intake of low-fat dairy was much 
higher than intake of high-fat dairy. Low-fat dairy intake was stable over time for both the 
Intervention and the Generic-advice group (p>0.05). Both the Intervention and Generic-advise 
groups showed a reduction in high-fat dairy intake (p<0.001 and p=0.01, respectively), 
although median intake levels were more stable in the Generic-group. Across product 
categories and groups, milk exhibited the highest median intake at around 170 g/day, followed 
by yoghurt (around 53 g/day) and cheese (around 24 g/day). There was no change over time in 
daily intake in any of the individual product categories for the Generic-advice group, while in 
the Intervention group there was a decrease in cream, cheese, and butter, with the largest 
relative change for butter. 
Median intake of oily fish at baseline (t0) was about 16 g/day in the Generic-advice and 
Intervention groups, increasing at t6 to 21.1 (±27.6) g/day in the Generic-advice group and 
23.5 (±29.9) g/day in the Intervention group.  
3.3 Reproducibility over time of biomarkers of dairy intake 
Across the three time points, levels of C15:0 and C17:0 in the Generic-advice group 
were 0.21% (sd=±0.06) and 0.32% (±0.06) respectively. Similar values were observed in the 
Intervention group (Table 3). Over time mean C17:0 levels showed an increase in t3 and a 
subsequent decrease in t6 (p<0.001). In contrast, average C15:0 levels remained stable in the 
Generic-advice group, but increased slightly in the Intervention group (p=0.014). In an attempt 
to benchmark the C15:0 and C17:0 results the levels of the well-established marker of oily fish 
were examined (EPA+DHA). EPA+DHA levels were 3.8% in t0 for the Generic-advice and 
Intervention groups, significantly increasing (p<0.05) to 3.9% and 4.1% in t3 for the Generic-
advice group and the Intervention group, respectively. 
Measures of agreement between the baseline and repeat blood fatty acid levels are 
shown in Table 4. Blood levels of C15:0 showed high correlation over time (ICC of 0.62, 95% 
confidence interval (CI): 0.57, 0.68), but the ICC for C17:0 was much lower, at 0.32 (95% CI: 
0.28, 0.46). The ICC for C15:0 was comparable to the values obtained for EPA+DHA (0.67, 
95% CI: 0.62, 0.71). The WCV for C15:0 was 16.6% (95% CI: 14.9%, 18.3%), and WCV for 
C17:0 was 14.6% (95% CI: 13.3%, 16.0%). In comparison, EPA+DHA had a WCV of 17.4% 
(95% CI: 16.1%, 18.8%). Finally, the highest Spearman rank correlation coefficients were 
observed between the baseline (t0) and t3 measurements. As with the ICCs, the highest values 
were observed for the dietary biomarker C15:0 (t0-t3: 0.69, 95% CI: 0.61, 0.78). C17:0 
exhibited correlation coefficients approximately half the values of C15:0. EPA+DHA had the 
highest correlation coefficients of the three biomarkers (t0-t3: 0.72, 95% CI: 0.69, 0.82) (Table 
4).  
3.4 Change in dietary intake and change in fatty acid levels  
Results indicate that an additional portion of high-fat dairy increased the DBS level of 
C15:0 by 0.32% (95% CI: 0.05%, 0.6%), whereas an increase of one portion per day of cheese 
and of butter increased C15:0 DBS levels by 1.8% (95% CI: 0.5%, 3.0%) and by 3.3% (95% 
CI: 1.3%, 5.3%), respectively (Table 5). The effect of an increase of butter intake on C15:0 
levels was similar to the change observed on EPA + DHA, with an increase of 2.6% (95% CI: 
1.3%, 3.9%, p<0.001) for an increase of one portion per day of oily fish. Greater intakes of 
high-fat dairy also raised the levels of C17:0 by 0.3% (95% CI: 0.098%, 0.45%); in addition, 
levels of this fatty acid rose by 9.4% (95% CI: 3.4%, 15.4%) in response to an additional daily 
portion of dairy cream. There were no significant effects detected in the levels of C15:0 and of 
C17:0 for changes in total low-fat dairy and lower-fat dairy products, such as total milk and 
yoghurt4.  
4 Discussion 
Using data from a Pan-European dietary intervention study, this study provides 
evidence on the reproducibility over time for repeated measures of blood C15:0 levels in DBS. 
Furthermore, the results demonstrate the association between changes in daily intakes of 
specific high-fat dairy products and blood levels of the odd-chain fatty acids C15:0 and C17:0. 
For C15:0, the ICC value and Spearman correlation were satisfactory and comparable 
to the values found for the well-established biomarker EPA+DHA. In contrast, C17:0 levels 
showed low correlations over time (ICC<0.35). The ICC results for C17:0 may have been 
weakened by the temporary increase in the levels of this fatty acid between baseline (t0) and 
t3, although sensitivity analyses excluding t3 observations did not show any improvement in 
the ICC for this fatty acid. Further evidence of reproducibility for C15:0 was found from the 
WCV analyses, which also presented good evidence of reproducibility for C17:0. The apparent 
contradiction in the evidence of reproducibility for C17:0 from the ICC and the WCV values 
                                                 
4 On average, the proportion in the sample of semi-skimmed and skimmed milk over total milk 
consumption was 79.7% (95% CI: 78.5%, 80.9%), and the proportion of plain or flavoured low-fat yoghurts over 
total yoghurt consumption was 82.4% (95% CI: 81.3%, 83.4%). 
could result from endogenous metabolic synthesis pathways for odd-chain saturated fatty acids 
such as C15:0 and C17:0. The existence of such pathways has been postulated on the basis of 
the higher levels of C17:0 observed in different lipid fractions in humans compared to what 
would be expected from the ratio of these fatty acids in milk fat [4, 23-25]. More recently 
strong evidence has emerged that supports the endogenous biosynthesis of C17:0 [26]. This 
biosynthesis of C17:0  could explain higher mean levels of heptadecanoic acid in the current 
data and the lower ICCs.   
Associations between changes in dairy intake and C15:0 and C17:0 DBS levels were 
not significant for low-fat dairy products. This supports our previous work [3], and is probably 
explained by the fact that  low-fat dairy products have low levels of milk fats including the 
odd-chained fatty acids C15:0 and C17:0 [2]. Higher intakes of high-fat dairy, total dairy, 
cheese and butter were associated with an increase in C15:0 DBS levels, with the largest effects 
for butter followed by cheese. The strong link between change in butter intake and C15:0 levels 
observed here reinforces previous evidence [3] and underscores the potential usefulness of this 
fatty acid as a biomarker of butter intake for prospective studies of cardiovascular health [27]. 
C17:0 levels changed in response to higher consumption of high-fat dairy and cream. In 
particular, cream consumption had a strong effect on C17:0 levels (≈ 10% increase). Cream is 
not a fermented dairy product and this may have played a role in the magnitude of this effect 
since bacteria in fermented products may affect lipid metabolism and interfere with plasma 
fatty acid levels [28], although this explanation remains to be explored for C17:0 and C15:0.  
An important strength of this study is the use of three blood DBS measurements over 
six months in a large sample of participants in groups of both relatively stable dairy intakes 
and changing dairy intakes in order to study the reproducibility and sensitivity of blood C15:0 
and C17:0 levels. The dietary intake data for the study came from purposely-designed and 
validated FFQ questionnaires [17, 18], nonetheless, consideration when evaluating the results 
should be given to the possible attenuation in the strength of the observed diet-biomarker 
relationships from using FFQ to capture intakes [4]. 
In conclusion, blood C15:0 levels showed strong evidence of reproducibility over time 
and sensitivity to change in intake of high-fat dairy products, comparable to the values found 
for the well-established biomarker EPA+DHA for oily fish intake, which are important 
conditions for the usefulness of biomarkers in the study of dietary intakes and nutrient-disease 
relationships. Results for C17:0 question its role as a dietary biomarker and supports recent 
research demonstrating substantial biosynthesis of C17:0 [26, 29]. This taken together with our 
previous results supports  C15:0  only as a biomarker of dairy intake [3].  
 
 
Table 1. Demographic and anthropometric characteristics of sample participants 
  Generic-advice group   Intervention group 
 t0 t3 t6     t0 t3 t6   
  N=289 N=243 N=228 p-value   N=889 N=777 N=722 p-value 
Men (%) 38 41 42 0.995   40 42 41 0.946 
Age (years) 39.4 (13.2) 40.3 (13.1) 40.9 (13.1) N/A   40.6 (12.9) 40.9 (13.1) 41.5 (12.9) N/A 
Smoker (%) 15 14 15 0.978   11 10 10 0.792 
BMI (kg/m2) 25.1 (4.6) 24.4 (3.9) 24.4 (3.9) 0.048   25.3 (4.9) 24.9 (4.5) 24.7 (4.1) p<0.001 
Waist circumference (cm) 84.6 (13.4) 83.4 (12.5) 83.6 (12.5) 0.042   84.9 (13.3) 84.1 (12.8) 83.8 (12.2) p<0.001 
Total energy intake (MJ/day) 10.4 (3.1) 10.2 (2.9) 10 (3.1) 0.008   10.7 (3) 9.7 (2.7) 9.8 (2.8) p<0.001 
Energy intake from dairy (%) 13.1 (7) 13.1 (6.7) 13 (6.2) 0.178   12.3 (6.3) 12.5 (6.2) 12.1 (6.1) 0.233 
Total energy from fat (%) 35.6 (5.8) 35.5 (5.8) 35.7 (6.5) 0.829   35.9 (5.8) 35 (5.4) 34.8 (5.6) 0.003 
Total fat intake from dairy (%) 17.3 (9.6) 17.5 (9) 16.9 (8.4) 0.250   16.2 (8.3) 16.3 (8.3) 15.8 (8.1) 0.293 
Energy intake from meat and fish (%) 13.4 (7) 13.4 (8) 14.5 (8.1) 0.022   13.9 (7.2) 14.1 (6.8) 14.1 (7) 0.007 
Total fat intake from meat and fish (%) 17.9 (9.3) 17.8 (9.8) 18.7 (9.1) 0.006   18.6 (9.3) 18.8 (8.8) 19 (8.9) 0.003 
Standard deviation in parenthesis. t0 is baseline, t3 and t6 are three months and six months form baseline, respectively. p-value from a repeated 
measures Skilling-Mack test (continuous variables) and logistic regression (binary variables). 
 
Table 2. Mean and median daily (g/day) dairy and oily fish intake across study periods 
  Generic-advice group   Intervention group  
  t0 t3 t6 p-value  t0 t3 t6 p-value 
  N=289 N=243 N=228    N=889 N=777 N=722   
Total dairy                  
Mean (sd) 371.9 (295.3) 362.4 (243.4) 354.4 (229.8) 0.033  357.2 (260.8) 335 (232.1) 336.1 (232.7) 0.007 
Median (iqr) 306.7 (290.5) 327.6 (263.5) 301.8 (265.6)    301.6 (272.5) 288.6 (256.8) 288.9 (269)   
High-fat dairy                  
Mean (sd) 26.1 (26.2) 25.5 (26.7) 23.5 (22.4) 0.010  27.3 (27.5) 18.6 (18.4) 18.4 (18.9) p<0.001 
Median (iqr) 17.1 (31.7) 20.3 (24.9) 18.6 (27.2)    19.3 (30.5) 13 (21) 12.8 (20.2)   
Low-fat dairy                  
Mean (sd) 317.8 (269.1) 308.9 (232.1) 308.8 (219.6) 0.568  307.9 (252.5) 287.6 (219.9) 297.6 (221.2) 0.189 
Median (iqr) 264.8 (288.3) 269.9 (266.9) 258.3 (259.9)    249 (263.3) 250 (246.4) 252 (261.5)   
Milk                  
Mean (sd) 217.9 (232.7) 210.9 (201.7) 210.7 (191.9) 0.535  212.3 (226.3) 186.3 (202) 193.3 (197.4) p<0.001 
Median (iqr) 174.4 (270) 189 (262.5) 189 (262.5)    177.7 (262.5) 148.5 (216.3) 161.1 (239)   
Cream                  
Mean (sd) 2.3 (4) 2.3 (3.8) 2.2 (3.7) 0.719  2.7 (6.5) 2.1 (3.8) 2 (4) p<0.001 
Median (iqr) 0 (3.2) 0 (3.9) 0 (3.2)    1.1 (3.8) 0 (2.9) 0 (3)   
Yoghurt                  
Mean (sd) 84.8 (96.9) 82.9 (91.4) 79.5 (90.9) 0.351  78.9 (101) 82.6 (93.1) 85.6 (99.8) 0.849 
Median (iqr) 53.6 (107.1) 53.6 (111.6) 53.6 (110.5)    53.6 (89.3) 53.6 (98.2) 53.6 (104.9)   
Cheese                  
Mean (sd) 34.8 (32.7) 33.1 (35.2) 35.1 (35.9) 0.228  35 (35.3) 31.5 (30.5) 31.4 (32.2) p<0.001 
Median (iqr) 25.7 (42.4) 22.9 (31.8) 25.4 (37.4)    24.1 (34.4) 22.3 (31.6) 21.9 (30.9)   
Butter                  
Mean (sd) 4.6 (8.4) 5.3 (10.8) 4.7 (10.9) 0.186  6.2 (12) 3.8 (7.6) 3.7 (8.5) p<0.001 
Median (iqr) 0.6 (6.4) 1.1 (6.4) 0.6 (6.4)    1.1 (6.4) 0.6 (3.9) 0.9 (3.9)   
Oily fish                  
Mean (sd) 23.9 (26.2) 30.1 (29.5) 27.6 (26) p<0.001  24.4 (27.4) 30.2 (28.4) 31.2 (38.1) p<0.001 
Median (iqr) 16.6 (24.5) 21.9 (27.1) 21.1 (27.6)    16.1 (25.4) 22.4 (30.9) 23.5 (29.9)   
sd: standard deviation, iqr: interquartile range. t0 is baseline, t3 and t6 are three months and six months form baseline, respectively. p-value from 
a repeated measures Skilling-Mack test. High-fat dairy category includes double cream, high-fat cheese, medium-fat cheese and butter. Low-fat 
dairy category includes full-fat or whole milk, low-fat or semi-skimmed milk, zero-fat or skimmed milk, single or sour cream, fruit yoghurt or 
fruit mousse, full-fat Greek yoghurt, low-fat natural yoghurt, low-fat cheese, and very low-fat cheese. 
 
Table 3. Mean and standard deviations across study periods of blood levels of fatty acids pentadecanoic (C15:0), heptadecanoic (C17:0), 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
 Generic-advice group  Intervention group 
  t0 t3 t6 Total p-value  t0 t3 t6 Total p-value 
  (289) (243) (228) (760)    (889) (777) (722) (2388)   
Pentadecanoic (C15:0)                      
Mean 0.20 0.21 0.21 0.21 0.145  0.20 0.21 0.21 0.21 0.014 
sd 0.06 0.05 0.06 0.06    0.06 0.05 0.06 0.06   
Between sd       0.05          0.05   
Within sd       0.03          0.03   
            
Heptadecanoic (C17:0)                      
Mean 0.32 0.34 0.31 0.32 p<0.001  0.32 0.34 0.31 0.32 p<0.001 
sd 0.05 0.07 0.05 0.06    0.06 0.07 0.07 0.06   
Between sd       0.05          0.05   
Within sd       0.04          0.04   
            
EPA+DHA            
Mean 3.75 4.01 3.93 3.89 0.033  3.77 4.04 4.07 3.95 p<0.001 
sd 1.17 1.19 1.17 1.18    1.25 1.30 1.29 1.28   
Between sd       1.09          1.17   
Within sd       0.49          0.56   
sd: standard deviation. Between sd: between-subject standard deviation, Within sd: within-subject standard deviation. t0 is baseline, t3 and t6 are 
three months and six months form baseline, respectively. Number of observations in parentheses. p-value from a repeated measures ANOVA with 
Box's conservative correction factor.  
 
Table 4. Estimates for intra-class correlation coefficients (ICC), within-subject coefficient of 
variation (WCV) and Spearman correlations for measurement of blood fatty acid levels over 
time  
Fatty acid N (n) ICC 
95% CI§  
(Lower limit) 
95% CI  
(Upper limit) 
C15:0 760 (334) 0.62 0.57 0.68 
C17:0 760 (334) 0.32 0.28 0.46 
EPA+DHA 760 (334) 0.67 0.62 0.71 
Fatty acid N WCV 
95% CI  
(Lower limit) 
95% CI  
(Upper limit) 
C15:0 760 (334) 16.6 14.9 18.3 
C17:0 760 (334) 14.6 13.3 16.0 
EPA+DHA 760 (334) 17.4 16.1 18.8 
Fatty acid (n) 
Spearman 
correlation* 
95% CI  
(Lower limit) 
95% CI  
(Upper limit) 
C15:0     
t0 – t3 205 0.69 0.61 0.78 
t3 – t6 196 0.67 0.58 0.76 
t0 – t6 194 0.66 0.57 0.76 
C17:0     
t0 – t3 205 0.47 0.36 0.59 
t3 – t6 196 0.38 0.26 0.51 
t0 – t6 194 0.36 0.22 0.49 
EPA+DHA     
t0 – t3 205 0.75 0.69 0.82 
t3 – t6 196 0.68 0.60 0.76 
t0 – t6 194 0.68 0.59 0.77 
N (n): total number of observations (number of participants). ICC, Spearman correlations and 
coefficient of variation calculated for fatty acid levels in dry blood spot samples. ICC 
calculated on the log-transformed fatty acid levels using the variance components from a 
random effects model. WCV calculated on the logarithmic scale using a one-way random 
effects model with MLE estimation procedure. *Unadjusted Spearman correlations. 
§Confidence intervals from bootstrap with 1000 replications. Generic-advice group only. 
 
Table 5. Association between change in dairy (portion/day) and % change in blood pentadecanoic acid (C15:0) and heptadecanoic acid (C17:0) 
levels* 
 C15:0 C17:0 
 b se p (95% CI ) b se p (95% CI ) 
Total dairy 1.02 0.5 0.023 (0.14,1.91) 0.09 0.4 0.829 (-0.75,0.93) 
High-fat dairy 0.32 0.1 0.019 (0.05,0.58) 0.27 0.1 0.002 (0.1,0.45) 
Low-fat dairy 0.19 0.3 0.483 (-0.35,0.73) 0.21 0.3 0.415 (-0.29,0.71) 
Milk 0.39 0.8 0.649 (-1.28,2.05) -0.26 0.8 0.736 (-1.74,1.23) 
Cream 4.74 2.8 0.091 (-0.77,10.25) 9.42 3.0 0.002 (3.43,15.4) 
Yoghurt 0.46 1.0 0.635 (-1.44,2.36) -0.79 0.9 0.399 (-2.64,1.05) 
Cheese 1.77 0.6 0.006 (0.52,3.02) 0.69 0.6 0.208 (-0.39,1.78) 
Butter 3.34 1.0 0.001 (1.34,5.35) 1.3 1.2 0.271 (-1.01,3.61) 
*All regressions adjusted for total energy intake, age, BMI, and smoking status; as well as intake of alcohol, meat, oily fish, savoury pastries and 
sweet pastries. se: standard error, p: p-value. High-fat dairy category includes double cream, high-fat cheese, medium-fat cheese and butter. Low-
fat dairy category includes full-fat or whole milk, low-fat or semi-skimmed milk, zero-fat or skimmed milk, single or sour cream, fruit yoghurt or 
fruit mousse, full-fat Greek yoghurt, low-fat natural yoghurt, low-fat cheese, and very low-fat cheese. Intervention group only. 
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